Clinical Trial Update: A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC [Phase 2]

View source ↗

Summary

Phase 2 trial updating radiotherapy dose/fractionation and omission of CTVs in limited-stage small cell lung cancer (SCLC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Small Cell Lung Cancer Limited Stage | Phase 2 | Status: UNKNOWN